《Synthesis and antitumor activities investigation of a C-nucleoside analogue of ribavirin》 was published in European Journal of Medicinal Chemistry in 2020. These research results belong to Sabat, Nazarii; Migianu-Griffoni, Evelyne; Tudela, Tiffany; Lecouvey, Marc; Kellouche, Sabrina; Carreiras, Franck; Gallier, Florian; Uziel, Jacques; Lubin-Germain, Nadege. Reference of Ethyl propiolate The article mentions the following:
SRO-91 is a non-natural ribofuranosyl-1,2,3-triazole C-nucleoside I obtained by a synthetic sequence involving a C-alkynyl glycosylation mediated by metallic indium and a Huisgen cycloaddition for the construction of the triazole. Its structure is close to the one of ribavirin, a drug presenting a broad-spectrum against viral infections. SRO-91 antitumor activities were investigated on 9 strains of tumor cells and IC50 of the order of 1μM were obtained on A431 epidermoid carcinoma cells and B16F10 skin melanoma cells. In addition, studies of ovarian tumor cell inhibitions show an interesting activity in regard to the need for new drugs for this pathol. Finally, cytotoxicity and mouse toxicity studies reveal a favorable therapeutic index for SRO-91. In the experimental materials used by the author, we found Ethyl propiolate(cas: 623-47-2Reference of Ethyl propiolate)
Ethyl propiolate(cas: 623-47-2) is a clear colorless to pale yellow liquid that is soluble in ethanol, ether and chloroform. It an important organic chemical raw material and pharmaceutical intermediate. Ethyl propargylate is obtained by oxidation of propargyl alcohol to propargylic acid followed by esterification.Reference of Ethyl propiolate
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics